Mochida Pharmaceutical Co., Ltd. (FRA:MFY)
Germany · Delayed Price · Currency is EUR 18.60
+0.40 (2.20%)
Last updated: Nov 25, 2025, 8:05 AM CET
Mochida Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 9,164 | 8,052 | 6,160 | 9,044 | 14,591 | 11,900 | Upgrade |
Depreciation & Amortization | 2,943 | 2,940 | 2,808 | 2,672 | 2,689 | 2,742 | Upgrade |
Loss (Gain) From Sale of Assets | 3 | 14 | -22 | 53 | 112 | 107 | Upgrade |
Loss (Gain) From Sale of Investments | - | - | -100 | - | -526 | - | Upgrade |
Loss (Gain) on Equity Investments | 583 | 618 | 168 | - | - | - | Upgrade |
Other Operating Activities | -1,962 | -951 | -1,366 | -4,172 | -5,709 | -2,121 | Upgrade |
Change in Accounts Receivable | -3,136 | 3,220 | -7,032 | 3,869 | -2,486 | -740 | Upgrade |
Change in Inventory | -3,086 | -3,016 | -5,873 | -1,277 | -521 | 2,466 | Upgrade |
Change in Accounts Payable | 1,158 | -3,522 | 2,225 | -1,941 | 2,176 | -3,934 | Upgrade |
Change in Other Net Operating Assets | -788 | 1,999 | -4,448 | -951 | -2,867 | -1,222 | Upgrade |
Operating Cash Flow | 4,879 | 9,354 | -7,480 | 7,297 | 7,459 | 9,198 | Upgrade |
Operating Cash Flow Growth | -29.99% | - | - | -2.17% | -18.91% | -1.59% | Upgrade |
Capital Expenditures | -2,071 | -2,160 | -2,296 | -2,166 | -2,988 | -1,935 | Upgrade |
Sale of Property, Plant & Equipment | 3 | 2 | 56 | - | - | 204 | Upgrade |
Investment in Securities | 11,700 | 19,500 | 2,301 | -1,100 | 1,098 | 1,000 | Upgrade |
Other Investing Activities | 14 | 13 | 13 | 317 | -117 | -149 | Upgrade |
Investing Cash Flow | 9,646 | 17,355 | 74 | -2,949 | -2,007 | -880 | Upgrade |
Repurchase of Common Stock | -2 | -3 | -3,492 | -3,512 | -2,511 | -2,008 | Upgrade |
Common Dividends Paid | -2,835 | -2,835 | -2,887 | -3,372 | -3,445 | -3,103 | Upgrade |
Other Financing Activities | -27 | -27 | -14 | - | - | -1 | Upgrade |
Financing Cash Flow | -2,864 | -2,865 | -6,393 | -6,884 | -5,956 | -5,112 | Upgrade |
Foreign Exchange Rate Adjustments | 65 | 16 | 79 | 32 | 31 | -9 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 1 | -2 | Upgrade |
Net Cash Flow | 11,726 | 23,860 | -13,720 | -2,504 | -472 | 3,195 | Upgrade |
Free Cash Flow | 2,808 | 7,194 | -9,776 | 5,131 | 4,471 | 7,263 | Upgrade |
Free Cash Flow Growth | -46.48% | - | - | 14.76% | -38.44% | -1.70% | Upgrade |
Free Cash Flow Margin | 2.57% | 6.84% | -9.50% | 4.97% | 4.06% | 7.05% | Upgrade |
Free Cash Flow Per Share | 79.21 | 202.93 | -272.59 | 138.08 | 117.34 | 188.00 | Upgrade |
Cash Interest Paid | 18 | 18 | 37 | 35 | 36 | 36 | Upgrade |
Cash Income Tax Paid | 1,954 | 948 | 1,368 | 3,224 | 3,616 | 2,154 | Upgrade |
Levered Free Cash Flow | 1,617 | 6,041 | -10,050 | 5,890 | 5,615 | 8,755 | Upgrade |
Unlevered Free Cash Flow | 1,619 | 6,042 | -10,049 | 5,890 | 5,615 | 8,755 | Upgrade |
Change in Working Capital | -5,852 | -1,319 | -15,128 | -300 | -3,698 | -3,430 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.